Publications by authors named "Postl Magdalena"

Claim this Profile
N
Novel Treatment Concepts for Cervical Cancer-Moving Towards Personalized Therapy.
Melina Danisch, Magdalena Postl, Thomas Bartl, Christoph Grimm, Alina Sturdza

J Pers Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer.
Valentina Glueck, Christoph Grimm, Magdalena Postl, Christian Brueffer, Nuria Segui

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Predictive Value of the Fibrinogen-Albumin-Ratio Index on Surgical Outcomes in Patients with Advanced High-Grade Serous Ovarian Cancer.
Magdalena Postl, Melina Danisch, Fridolin Schrott, Paul Kofler, Patrik Petrov

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic and Obstetric Outcomes Following Radical Abdominal Trachelectomy in Non-Low-Risk Early-Stage Cervical Cancers: A 10-Year Austrian Single-Center Experience.
Melina Danisch, Marlene Kranawetter, Thomas Bartl, Magdalena Postl, Christoph Grimm

J Pers Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful one-stage resection of intracardiac intravenous leiomyomatosis: A case report.
Postl Magdalena, Bartl Thomas, Poetsch Nina, Reinthaller Alexander, Andreas Martin

Gynecol Oncol Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients.
Thomas Bartl, Jasmine Karacs, Caroline Kreuzinger, Stephanie Pfaffinger, Jonatan Kendler, Magdalena Postl

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer.
Thomas Bartl, Christine Bekos, Magdalena Postl, Reinthaller Alexander, Stephan Polterauer

J Gynecol Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of serum creatine level in patients with vulvar cancer.
Richard Schwameis, Magdalena Postl, Christine Bekos, Lukas Hefler, Alexander Reinthaller

Sci Rep· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis